Redhill Biopharma
RDHL
#11160
Rank
ยฃ1.9 M
Marketcap
ยฃ0.21
Share price
-13.08%
Change (1 day)
-73.71%
Change (1 year)

Earnings for Redhill Biopharma (RDHL)

Earnings in 2022: -ยฃ54.79 Million

According to Redhill Biopharma's latest financial reports the company's current earnings are ยฃ35.74 Million. In 2022 the company made an earning of -ยฃ54.79 Million, an increase over its 2021 earnings that were of -ยฃ74.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Redhill Biopharma from 2012 to 2022

Annual earnings

Year Earnings Change
2022-ยฃ54.79 Million-26.68%
2021-ยฃ74.72 Million28.32%
2020-ยฃ58.23 Million80.06%
2019-ยฃ32.34 Million8.97%
2018-ยฃ29.68 Million-14.76%
2017-ยฃ34.82 Million55.07%
2016-ยฃ22.46 Million39.26%
2015-ยฃ16.13 Million96.9%
2014-ยฃ8.19 Million0.78%
2013-ยฃ8.13 Million16.93%
2012-ยฃ6.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
ยฃ5.95 B 67,200.64%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ5.13 B 57,997.13%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ5.46 B 61,725.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ0.93 B 10,477.26%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
ยฃ33.42 M 277.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel